Stem Cells Market and Drug Discovery Applications, 2009-2015

15 Nov 2010 • by Natalie Aster

London – “The stem cell market is expected to witness a substantial growth in the upcoming years, with a CAGR of 24.2%, globally. Although North America will likely post highest market value by 2015, Asian economies are expected to maintain large CAGR of 27 percent during 2010-2015. The higher growth rate indicates improved industry investments in the Asia-Pacific region in comparison with North America and Europe, going ahead.”

The report “Stem Cells Market and Drug Discovery Applications, 2009-2015” by Axis Research Mind reviews latest Stem Cells market trends with a perceptive to disclose the near-future growth prospects. It offers profitable investment strategies for stem cell banks, stem cells R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on latest market trends, region-wise demand factor key growth, areas market sizes, key competitors’ edge, investment strategies.

The report delivers a microscopic study of major stem cells product segments and applications of drug discovery in stem cells market, worldwide. The stem cells product segments include adult stem cells, cord blood stem cells, embryonic stem cells and others. The major stem cells drug discovery applications discussed in the report are:

  • Cell Therapy and Regenerative Medicine;
  • High-Content Screening Assays and Toxicology;
  • Replacement of Damaged Cells.

Report Details:

Stem Cells Market and Drug Discovery Applications, 2009-2015
Published: July 2010
Pages: 410
Price: USD 3,783.00

Report Sample Abstract:

Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during the period 2010-2015. In terms of drug discovery applications using stem cells, North America and Europe account for more than 60% of the market value. However, the largest growth rate during 2009-2015 is expected from Asia-Pacific, a CAGR of 26.5%. China, India, Greece, Spain, Sweden, Germany and the US are at the forefront in driving the sector growth with an annual growth rate of more than 27% during the period. Brazil and Argentina are the Latin American majors in drug discovery applications using stem cells. Stem cells use in replacing damaged cells is expected to witness highest investments in the upcoming years as the CAGR forecasts for the sector is high. Estimates for cell therapy and regenerative medicine market indicate a CAGR of nearly 24% CAGR during 2009-2015.

Improving health consciousness in Europe will likely maintain the stem cell market of the European Union competent with Asia-Pacific/North America. India possesses the potential to occupy the leading position in stem cell market growth with a CAGR exceeding 28 percent through 2015. Spain, Sweden and Germany are anticipated to top among the European countries with an annual compounded growth rate of more than 27 percent respectively through 2010-2015. Latin American countries will not likely experience a massive growth rate in comparison with North American/Asian economies. Overall, emerging economies could tag higher growth rate stem cells market in the next few years.

More information can be found in the report “Stem Cells Market and Drug Discovery Applications, 2009-2015” by Axis Research Mind.

To order the report or ask for free sample pages contact


MarketPublishers, Ltd.
Mrs. Alla Martin
Tel: +44 208 144 6009
Fax: +44 207 900 3970